ADIL — Adial Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Adial Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4.4	6.06	4	2.83	3.75
Prepaid Expenses
Total Current Assets	5.14	6.46	4.78	3.2	4.06
Net Property, Plant And Equipment	—	0.304	0.244	—	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	5.49	7.47	5.73	4.74	5.04
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.51	2.72	1.79	0.653	0.976
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1.51	3.97	2.46	0.653	0.976
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	3.99	3.51	3.28	4.08	4.07
Total Liabilities & Shareholders' Equity	5.49	7.47	5.73	4.74	5.04
Total Common Shares Outstanding